| Q64126765 | Q64126765 |
| Q34390072 | 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host |
| Q35038217 | Biological feasibility of measles eradication |
| Q40560650 | British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015. |
| Q47115336 | Challenges to global measles eradication: is it all in the timing? |
| Q37272364 | Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities |
| Q38212517 | Current progress in pulmonary delivery of measles vaccine |
| Q85527217 | Editorial: recent advances in HIV infection |
| Q64101082 | Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants |
| Q38205649 | HIV and schistosomiasis co-infection in African children |
| Q92879601 | High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study |
| Q36663470 | Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa. |
| Q38039620 | Immunising the HIV-infected child: a view from sub-Saharan Africa |
| Q37983027 | Immunization of HIV infected children |
| Q38284708 | Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis |
| Q37309246 | Low vaccine coverage among children born to HIV infected women in Niamey, Niger |
| Q38560170 | Measles vaccine: Past, present, and future |
| Q40485483 | Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany |
| Q45078665 | Measurement of vaccine-derived immunity: how do we use all the data? |
| Q90214218 | Precision immunization: a new trend in human vaccination |
| Q36062346 | Risk Factors for Measles in HIV-infected Children and Adolescents in Botswana |
| Q63812138 | Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis |
| Q60043901 | Seroprevalence of measles vaccine antibody response in vertically HIV-infected children, in Morocco |
| Q40070937 | Seroprevalence of transplacentally acquired measles antibodies in HIV-exposed versus HIV-unexposed infants at six months of age. |
| Q28365025 | Sun protection to improve vaccine effectiveness in children in a high ambient ultraviolet radiation and rural environment: an intervention study |
| Q39009658 | Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules |
| Q35239262 | Susceptibility to Measles Among Perinatally HIV-Infected Adolescents and Young Adults |
| Q63683021 | The burden of vaccine-preventable diseases among HIV-infected and HIV-exposed children in sub-Saharan Africa: a systematic review and meta-analysis |
| Q63683024 | Vaccination among HIV–infected, HIV-exposed uninfected and HIV-uninfected children: A systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness |